What's new.
D000818:Animals; D002648:Child; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003513:Cycloheximide / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000276:immunology; D005347:Fibroblasts / Q000502:physiology; D011564:Furocoumarins / Q000009:adverse effects; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D051379:Mice; D009447:Neuroblastoma / Q000276:immunology; D010778:Photochemotherapy / Q000009:adverse effects; D011565:Psoriasis / Q000628:therapy; D012871:Skin Diseases; D012878:Skin Neoplasms / Q000139:chemically induced / Q000628:therapy; D013946:Thymopoietins / Q000502:physiology; D014582:Urticaria Pigmentosa / Q000188:drug therapy
D011564:Furocoumarins; D013946:Thymopoietins; D007372:Interferons; D003513:Cycloheximide; D004205:Cromolyn Sodium